...
transplant
Management of Complications
of Chronic Liver Disease:
“When to Refer to Transplant?”
Philip Rosenthal, M.D.
Professor of Pediatrics & Surgery
University of California,
San Francisco
Nutritional ... disease
MEDICAL MANAGEMENT OF
MEDICAL MANAGEMENT OF
LIVER TRANSPLANT
LIVER TRANSPLANT
CANDIDATES
CANDIDATES
• Management of complica...
... consumption of less than 10 g;
and (3) appropriate exclusion of other liver diseases based on
standard clinical, laboratory, imaging and/or liver biopsy
features. Laboratory tests to rule out other liver ... performed due to persistently abnormal liver
enzymes. Liver biopsy features including grade of steatosis,
inflammatory infiltrate, and ballooning, the presence of Ma...
...
identifying patients at high risk of COPD, followed by
watchful surveillance of these patients, is advised.
Respiratory Symptoms
Of the chronic symptoms characteristic of COPD
(dyspnea, cough, sputum ...
investigations of COPD risk factors, ways to reduce exposure
to these factors, and the molecular and cellular mechanisms
involved in COPD pathogenesis continue to be i...
... independent of the agent used. The group with the highest tertile
of BP reduction (-6.9 mmHg (-9.1 to -4.8) had a relative risk of ESRD of 0.74 (0.59 to 0.92).
138
A systolic BP of >130 mmHg ... proteinuria (RR of ESRD in ACE inhibitor group 0.69; 95% CI 0.51 to 0.94, doubling
of serum creatinine /ESRD combined 0.70; 95% CI 0.55 to 0.88).
Further analysis of this co...
... Journal of Haematology, 140, 255–266
production of NADPH oxidase-corrected granulocytes after gene
therapy of chronic granulomatous disease. Proceedings of the
National Academy of Sciences of the ... Journal of Hematology, 85, 70–72.
The International Chronic Granulomatous Disease Cooperative Study
Group (1991) A controlled trial of interferon gamma to prevent
infection...
... range of 3 mA down to 100 nA, was used for
treatment of chronic wounds and ulcers associated
with chronic disease (21). The device used in the ex-
periment was supposed to deliver electrons to ... the
mediator of damage to cellular components of insulin
production (33,39).
A major source of cellular reactive oxygen
spe-
cies is mitochondria, whose dysfunction cont...
... blood counts is to aggressively use hematopoietic
growth factors. The often poor tolerability of this
population to any interferon and ribavirin regimen
reflects a number of factors including ... Rodriguez-Luna H. Management of hepatitis C virus
infection in the setting of liver transplantation. Liver Transpl 2005;
11:479-89.
6. Charlton M. Liver biopsy, viral kineti...
... of ribavirin
and the virological monitoring procedure [19].
HCV genotype 1
Given the likelihood of a sustained virological
response, of the order of 40% to 50%, a precise assessment
of liver ... decision to treat patients
with chronic hepatitis C depends on multiple parameters,
including a precise assessment of the severity of liver
disease and of its foreseea...
...
b
b
i
i
o
o
g
g
r
r
a
a
p
p
h
h
y
y
John M. Vierling is Professor of Medicine at the David Geffen School of Medicine at
UCLA. He is the former Director of Hepatology and Medical Director of Multi-Organ
Transplantation ... with respect to risk or prevalence of reinfection, development of LAM
resistance or prevalence of precore mutations.
4. Management of Patients P...
... presence of DM were the independent
predictors of CVD in the earlier stages of CKD (Table
4).
Table 1: Characteristics of patients with CKD stage II to IV
excluding patient with history of renal ... Treatment of High Blood Pres-
sure have classified the presence of CKD as a cardio-
vascular risk factor (9, 13, 14). These findings led to the
evaluation of novel cardiov...